Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.

Share:
More In Business
Navigating Finances In A Relationship
Emily Irwin, managing director of advice & planning for Wells Fargo’s wealth & investment management arm, joined Cheddar News to discuss financial red flags when finding a partner.
Load More